The global laparoscopic devices system market by Product
Type ( Laparoscope, Hand Access Instrument, Energy Products,
Trocars/Access Device, Robot Assisted System, Insufflation Devices,
Suction/ Irrigation Device, and Closure Devices), by Application
(Bariatric Surgery, Colorectal Surgery, Gynecological Surgery, and
Urological Surgery) by End User (Hospital, Clinics, and Ambulatory
Surgical Centers ) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 7,635.2 million in 2016 and is projected to exhibit a CAGR of 7.7% over the forecast period (2017–2025), as highlighted in a report published by Coherent Market Insights. Increasing
demand for minimal invasive surgeries and advancement in technology in
laparoscopic devices is in turn projected to support growth of the
laparoscopic devices market over the forecast period.
Continuous upgradation of old surgical
instruments intended to be utilized in laparoscopic procedures is the
major factor for growth of laparoscopic devices market. For instance,
needle holder is used by surgeons to hold suturing needles during
laparoscopy. Probe, scalpel, and cannula together form a trocar, and is
widely used in laparoscopic surgeries. Bowel grasper enables surgeons to
grasp and manipulate abdomen tissue with precision.
Manufacturers are focusing on innovation
and new product launches to enhance its product portfolio and expand
its presence. For instance, in August 2017, Ethicon, a part of the
Johnson & Johnson Medical Devices Companies, launched the ProxiSure,
an advanced laparoscopic suturing device featuring Ethicon
endomechanical, suture, and curved needle technologies. Intuitive
Surgical, announced in May 2017, that the company’s new da Vinci X
Surgical System received US Food and Drug Administration (FDA). In
October 2017, the Senhance system, which is a robotically assisted
surgical device that can be used in laparoscopic colorectal and
gynecologic surgery, manufactured by TransEnterix Surgical, Inc.
received the U.S. FDA approval. Manufacturers are strategizing on
offering medical robotic systems at lower costs and with several
features, which in turn favors growth of laparoscopic devices market.
Browse 30 Market Data Tables and 24 Figures spread through 156 Pages and in-depth TOC on Laparoscopic
Devices Market by Product Type (Laparoscope, Hand Access Instrument,
Energy Products, Trocars/Access Device, Robot Assisted System,
Insufflation Devices, Suction/ Irrigation Device and Closure Devices),
by Application (Bariatric Surgery, Colorectal Surgery, Gynecological
Surgery, and Urological Surgery) by End User (Hospital, Clinics, and
Ambulatory Surgical Centers) and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2025
To know the latest trends and insights prevalent in the global laparoscopic devices market, click the link below:
Manufacturers are also focusing on
collaborations and acquisitions to strengthen their product portfolio
related to laparoscopic devices. For instance, Globus Medical acquired
KB Medical, a robotic company-based in Switzerland, in August 2017. This
acquisition aided in bolstering the product portfolio and intellectual
property of the Globus Medical. Stryker Corp. In September 2013, the
company also acquired Mako Surgical Corp and its robotic surgery
platform for around US$ 1.65 Bn, which helped Stryker to use its own
implants with Mako’s surgical systems. Zimmer Biomet entered the
surgical robotic market through the acquisition of a France-based
company Medtech SA, by purchasing around 59% of the outstanding share
capital of Medtech in July 2016. Medtech SA is a developer and
manufacturer of the ROSA robotic device used for neurological and spine
procedures, which had received FDA approval in January 2016.
Furthermore, Verily Life Sciences LLC in
collaboration with Johnson & Johnson, formed Verb Surgical Inc., in
March 2015. Verb Surgical focuses on developing a comprehensive
surgical solutions platform to improve access to minimal invasive
surgery. These are expected to favor growth of the laparoscopic devices
market.
However, high costs associated with
laparoscopic devices and lack of trained-healthcare professionals is
expected to act as a restraint for growth of the laparoscopic devices
market.
Key takeaways of the market:
- The global laparoscopic devices market is expected to exhibit a CAGR of 7% over the forecast period (2017–2025), owing to increasing demand for minimal invasive procedure. Asia Pacific region in the global laparoscopic devices market is expected to exhibit high growth rate, in terms of value, over the forecast period.
- Among product types, energy products segment is expected to exhibit a significant CAGR of 5%.
Some major players operating in the
global laparoscopic devices market are Stryker Corporation, Johnson
& Johnson, Karl Storz GmbH & Co.KG, Boston Scientific
Corporation, Medtronic PLC. (Covidien), Olympus Corporation, Richard
Wolf GmbH, ConMed Corporation, B. Braun Melsungen AG, and Smith &
Nephew PLC.
About Coherent Market Insights:
Coherent Market Insights is a prominent
market research and consulting firm offering action-ready syndicated
research reports, custom market analysis, consulting services, and
competitive analysis through various recommendations related to emerging
market trends, technologies, and potential absolute dollar opportunity.
Contact Us:Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
No comments:
Post a Comment